Drug name - Lansoprazole

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US11077055 DEXCEL PHARMA Orally disintegrating compositions Apr, 2036

(13 years from now)

Drugs and Companies using LANSOPRAZOLE ingredient

Treatment: NA

Dosage: TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE;ORAL

More Information on Dosage
Strength Dosage Availability
15MG TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE;ORAL Over the counter

availability in other generic markets.

Click on the highlighted region to filter.